Beraprost

Beraprost is an orally stable analogue of prostacyclin (PGI2) that produces vasodilatory and antiplatelet effects, used for pulmonary arterial hypertension and peripheral vascular disease. Simson Pharma's Beraprost reference standard and impurities support compendial testing for this vascular-disease therapy.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Beraprost Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Beraprost Impurity 3
Beraprost Impurity 4

Isotope Labelled Compounds

Beraprost d3